Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Strike Pharma AB
AB
Active
Org 5592842651
Scheeletorget 1, 223 63
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2020 · 5 years old
10-19 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Strike Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
-10M
-19M
-29M
-39M
-5M
2021
-24M
-380%
2022
-31M
-29%
2023
-14M
+55%
2024
Income statement
SEK thousands
Item
2021
2022
2023
2024
Revenue
0
0
0
0
Staff expenses
—
—
—
−2 309
EBITDA
−4 644
−23 602
−31 292
−13 745
Depreciation & amort.
−0
−0
−0
—
EBIT
−4 644
−23 602
−31 292
−13 745
Net financials
—
—
−412
−444
Profit before tax
−4 644
−23 602
−31 704
−14 189
Tax
−0
−0
−0
—
Net profit
−4 644
−23 602
−31 704
−14 189
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
Total assets
6 139
33 537
14 000
11 637
Equity
5 039
27 516
9 612
8 100
Long-term debt
0
0
0
—
Short-term debt
1 100
6 021
4 387
3 537
Total debt
1 100
6 021
4 387
3 537
Financial ratios
5-year trend
EBITDA margin
-1374484300.0%
This company
15.8%
Market median
-8699267822% vs market
2021
2024
Equity ratio
69.6%
This company
38.2%
Market median
+82% vs market
2021
2024
Return on equity
-175.2%
This company
18.4%
Market median
-1052% vs market
2021
2024
Net profit margin
-1418865900.0%
This company
8.1%
Market median
-17516863063% vs market
2021
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2024
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-12-31
View
PDF
More on Strike Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
